Page last updated: 2024-08-21

d-alpha tocopherol and Liver Steatosis

d-alpha tocopherol has been researched along with Liver Steatosis in 160 studies

Research

Studies (160)

TimeframeStudies, this research(%)All Research%
pre-199030 (18.75)18.7374
1990's9 (5.63)18.2507
2000's58 (36.25)29.6817
2010's61 (38.13)24.3611
2020's2 (1.25)2.80

Authors

AuthorsStudies
Clay, R; Siddiqi, S; Siddiqi, SA1
Atkinson, J; Bobe, G; Chung, S; Ebenuwa, IC; Ghelfi, M; Head, B; Herion, DW; Levine, M; Liu, CY; Manor, D; Niyyati, M; Padayatty, SJ; Shamburek, RD; Smith, S; Thakur, V; Traber, MG; Tu, H; Ulatowski, L; Violet, PC; Wang, Y; Wilkins, K1
de Miguel, M; Dossi, CG; González-Mañán, D; Pettinelli, P; Romero, N; Silva, D; Tapia, G1
Al-Okbi, SY; El-Ghlban, S; El-Qousy, SM; Moawad, HF1
Buldaeva, EA; Darenskaya, MA; Gavrilova, OA; Grebenkina, LA; Kolesnikov, SI; Kolesnikova, LI; Rychkova, LV; Zhdanova, LV1
Anez-Bustillos, L; Baker, MA; Cho, BS; Dao, DT; Fell, GL; Gura, KM; Nandivada, P; Nose, V; O'Loughlin, AA; Pan, A; Puder, M1
Abu Bakar, MR; Ansari, MA; Gopalan, Y; Khan, NA; Magosso, E; Ng, BH; Shuaib, IL; Wong, JW; Yuen, KH1
Doğru-Abbasoğlu, S; Giriş, M; Koçak-Toker, N; Kumral, A; Olgaç, V; Uysal, M1
Brown, L; Fong, CW; Ward, LC; Wong, WY; Yap, WN1
Angulo, P; Comparcola, D; Devito, R; Di Ciommo, V; Manco, M; Marcellini, M; Nobili, V; Piemonte, F; Sartorelli, MR1
Balsa, JA; Botella-Carretero, JI; Díaz-Enriquez, M; Escobar-Morreale, HF; Peromingo, R; Vázquez, C1
Miyazaki, H; Takitani, K; Tamai, H; Yoden, A1
Bruno, RS; Chung, MY; Park, HJ; Volek, JS; Yeung, SF1
Ackerman, Z; Grozovski, M; Oron-Herman, M; Pappo, O; Peleg, E; Safadi, R; Schmilovitz-Weiss, H1
Imaizumi, K; Kawakami, M; Nagata, K; Okubo, H; Ozaki, Y; Sato, M; Shiratake, S; Shirouchi, B; Tomoyori, H; Ueda, T1
Bedossa, P1
Asai, T; Ito, M; Kamiya, H; Matsubara, K; Matsui, H; Murohara, T; Okumura, K; Saburi, Y; Takahashi, R1
Hirata, D; Isoda, N; Kamata, Y; Kamimura, T; Kanai, N; Masuyama, J; Minota, S; Yoshio, T1
Dela Torre, AN; Dikdan, GS; Koneru, B; Roth, J; Saba, SC; Wang, S1
Hasegawa, T; Makino, I; Nakamura, K; Terano, A; Yoneda, M1
Hayakawa, T; Hayashi, K; Ito, M; Kamiya, H; Matsui, H; Okumura, K; Saburi, Y1
de Novellis, F; De Rosa, M; Giori, AM; Pirozzi, AVA; Schiraldi, C; Scognamiglio, I; Stellavato, A; Vassallo, V1
Ijaz, A; Khan, DA; Khan, S; Pervez, MA1
Carratù, MR; de Bari, O; Diogo, CV; Ferri, D; Grattagliano, I; Liquori, A; Mastrodonato, M; Oliveira, PJ; Persichella, M; Portincasa, P; Wang, DQ1
Clark, JM; Hoofnagle, JH; Kleiner, DE; Kowdley, KV; Loomba, R; Neuschwander-Tetri, BA; Sanyal, AJ; Tonascia, J; Van Natta, ML1
Inada, Y; Itoh, Y; Kanemasa, K; Naito, Y; Okanoue, T; Sakai, K; Sumida, Y; Taketani, H; Tanaka, S; Yasui, K; Yoshikawa, T1
Henry, L; Mehta, R; Mishra, A; Reyes, MJ; Younossi, ZM1
Allard, JP; Arendt, BM; Da Silva, HE; Guindi, M; Noureldin, SA; Therapondos, G1
Rinella, ME1
Argo, CK; Caldwell, SH; Ikura, Y; Lackner, C1
Baldini, F; Grasselli, E; Grattagliano, I; Portincasa, P; Vecchione, G; Vergani, L; Voci, A; Wang, DQ1
Jun, DW; Nguyen, MH; Oh, H; Saeed, WK1
Chalasani, NP; Hoofnagle, J; Kleiner, DE; Kowdley, KV; Robuck, PR; Sanyal, AJ; Tonascia, J; Unalp, A1
Baldeiras, I; Camilo, ME; Cortez-Pinto, H; Jesus, L; Machado, MV; Marques-Vidal, P; Oliveira, CR; Proença, T; Ravasco, P1
Kleiner, D; Lavine, JE; Molleston, J; Patton, HM; Schwimmer, JB; Van Natta, ML1
Calignano, A; Canani, RB; Cuzzocrea, S; Esposito, E; Iacono, A; Meli, R; Pacilio, M; Raso, GM1
Dhawan, A; Dziechciarz, P; Horvath, A; Socha, P; Szajewska, H; Vajro, P1
Balmer, ML; Dufour, JF; Siegrist, K; Zimmermann, A1
Fu, N; Li, LX; Liang, BL; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, JM; Zhao, SX1
Abrams, SH; Brunt, EM; Lavine, JE; Molleston, JP; Murray, KF; Robuck, PR; Rosenthal, P; Sanyal, AJ; Scheimann, AO; Schwimmer, JB; Tonascia, J; Unalp, A1
de Almeida, BB; Jordao, AA; Mathias, MG; Portari, GV1
Chavin, K; Ellett, JD; Evans, ZP; Fariss, MW; Fiorini, RN; Mandavilli, BS; Rodwell, D; Schmidt, MG; Schnellmann, RG1
Bass, NM; Brunt, EM; Chalasani, N; Clark, J; Diehl, AM; Hoofnagle, JH; Kleiner, DE; Kowdley, KV; Lavine, JE; McCullough, A; Neuschwander-Tetri, BA; Robuck, PR; Sanyal, AJ; Tonascia, J; Unalp, A; Van Natta, M1
Feres, MB; Jordão, AA; Leonardi, DS; Portari, GV; Zanuto, ME; Zucoloto, S1
Shen, L1
Armstrong, MJ; Houlihan, DD; Rowe, IA1
Cangemi, R; Violi, F1
Ji, HF; Shen, L1
Carani Venkatraman, A; Mohamed Salih, S; Muniyandi, P; Nallasamy, P; Periyasami, V1
Chen, HL; Kuo, YW; Tsai, CH; Wang, CH1
Lavine, JE; Mencin, AA1
Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J1
Guan, X; Lin, L; Tang, Y; Wang, L1
Deretzi, G; Katsiki, E; Kountouras, J; Patsiaoura, K; Polyzos, SA; Rakitzi, P; Slavakis, A; Tsarouchas, G; Zafeiriadou, E; Zavos, C1
Donner, A; Erhardt, A; Häussinger, D; Lirussi, F; Sies, H; Stahl, W1
Adinolfi, LE; Restivo, L1
Bellentani, S; Lonardo, A; Loria, P; Ratziu, V1
Abrams, SH; Brunt, EM; Chalasani, N; Clark, JM; Hoofnagle, JH; Kleiner, DE; Lavine, JE; Molleston, JP; Murray, KF; Robuck, PR; Rosenthal, P; Sanyal, AJ; Scheimann, AO; Schwimmer, JB; Tonascia, J; Ünalp, A; Van Natta, ML1
Adams, LA; Smith, BW1
Alisi, A; Nobili, V1
Arnold, LL; Cohen, SM; Kakiuchi-Kiyota, S; Koza-Taylor, P; Pennington, KL; Suzuki, S; Varney, M; Yokohira, M1
Mullin, GE1
Andrews, DB; Lavine, JE1
Dumortier, J; Guillaud, O; Hervieu, V; Pietu, F; Scoazec, JY; Vallin, M; Walter, T1
White, JS1
Belt, P; Colvin, R; Lavine, JE; Molleston, JP; Murray, KF; Rosenthal, P; Schwimmer, JB; Tonascia, J; Unalp, A; Vos, MB1
Andreone, P; Brisc, C; Brisc, MC; Bugianesi, E; Chiaramonte, M; Cursaro, C; Danila, M; de Sio, I; Del Vecchio Blanco, C; Federico, A; Floreani, A; Freni, MA; Grieco, A; Groppo, M; Lazzari, R; Lobello, S; Loguercio, C; Lorefice, E; Margotti, M; Miele, L; Milani, S; Okolicsanyi, L; Palasciano, G; Portincasa, P; Saltarelli, P; Smedile, A; Somalvico, F; Sorrentino, P; Spadaro, A; Sporea, I; Tuccillo, C; Vecchione, R1
Grønbæk, H; Heebøll, S; Kazankov, K; Poulsen, MK; Vilstrup, H1
Brunt, EM; Chalasani, N; Charlton, M; Cusi, K; Diehl, AM; Lavine, JE; Sanyal, AJ; Younossi, Z2
Bass, NM; Bell, LN; Brunt, EM; Chalasani, N; Chalasani, S; Diehl, AM; Fullenkamp, AM; Kowdley, KV; McCullough, AJ; Muralidharan, S; Neuschwander-Tetri, BA; Sanyal, AJ; Unalp-Arida, A; Wang, J; Wilson, LA1
Akcam, M; Boyaci, A; Dundar, BN; Kaya, S; Pirgon, O; Uysal, S1
Craig, JC; George, J; Mahady, SE; Wong, G1
Aouizerat, B; Cheng, J; Joyce, A; Sanyal, AJ; Yates, K1
Pacana, T; Sanyal, AJ1
Chiarelli, F; Chiavaroli, V; D'Adamo, E; de Giorgis, T; Giannini, C; Marcovecchio, ML; Mohn, A1
Beiraghdar, F; Ghamarchehreh, ME; Jalalian, HR; Panahi, Y; Sahebkar, A; Zare, R1
Bril, F; Cusi, K; Lomonaco, R; Sunny, NE1
Agrawal, S; Bonkovsky, HL1
Patrick, L1
Everhart, JE; Ruhl, CE1
Hill, DB; Kugelmas, M; Marsano, L; McClain, CJ; Vivian, B1
L'ABBATE, S1
SRIRAMACHARI, S1
COSTALES, F; DILUZIO, NR1
Adams, LA; Angulo, P2
Harrison, SA; Hayashi, P; Schenker, S; Torgerson, S; Ward, J1
Hasegawa, T; Kono, T; Nakamura, K; Tamano, M; Terano, A; Yoneda, M1
Franzese, A; Lucariello, S; Mandato, C; Vajro, P1
Harrison, SA; Schenker, S; Ward, JA1
Kowdley, KV1
Mitsuyoshi, H; Nakashima, T; Okanoue, T; Sumida, Y1
Clore, J; Contos, MJ; Luketic, VA; Mills, AS; Mofrad, PS; Sanyal, AJ; Sargeant, C; Shiffman, ML; Sterling, RK; Stravitz, RT1
Durst, PR; Elitsur, Y; Lawrence, Z; Wang, R1
Shen, W1
Bugianesi, E; David, E; Gentilcore, E; Manini, R; Marchesini, G; Natale, S; Rizzetto, M; Vanni, E; Villanova, N1
D'Auria, M; de Sio, I; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C1
Akarca, US; Akay, S; Batur, Y; Ersöz, G; Günşar, F; Karasu, Z1
Ahmed, MH1
Beucler, I; Bonnefont-Rousselot, D; Charlotte, F; Giral, P; Poynard, T; Ratziu, V1
Comar, KM; Sterling, RK1
Lavine, JE; Schwimmer, JB1
Harrison, SA1
Al-Osaimi, AM; Argo, CK; Caldwell, SH; Chang, CY1
de Sio, I; Del Vecchio Blanco, C; Di Leva, A; Federico, A; Loguercio, C; Trappoliere, M; Tuccillo, C1
Kadayifci, A; Merriman, RB1
Ciampalini, P; Devito, R; Manco, M; Marcellini, M; Nobili, V; Piemonte, F1
Alessandri, C; Angelico, F; Burattin, M; Del Ben, M; Lirussi, F1
Barve, S; Cave, M; Deaciuc, I; Joshi-Barve, S; McClain, C; Mendez, C; Song, Z1
Akyol, G; Bozkaya, H; Erdem, O; Erden, E; Ersoy, R; Guliter, S; Ozenirler, S; Savas, B; Yakaryilmaz, F1
Capasso, R; D'Auria, MV; de Sio, I; Del Vecchio Blanco, C; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C1
Hickman, I; Macdonald, G1
Bertini, E; Boldrini, R; Ciacco, E; Devito, R; Gaeta, LM; Marcellini, M; Nobili, V; Petrini, S; Piemonte, F; Tozzi, G1
Birkner, E; Birkner, K; Grucka-Mamczar, E; Kasperczyk, A; Kasperczyk, S; Stawiarska-Pieta, B; Zalejska-Fiolka, J1
Mensink, RP; Plat, J; Schrauwen, P1
Moseley, RH1
Fu, JF; Hong, F; Liang, L; Lu, JR; Wang, CL; Wu, XM; Xue, JZ; Zou, CC1
Di Luzio, NR; Hartman, AD1
Takahashi, Y1
Diaz, GJ; Julian, RJ; Squires, EJ1
Savage, JE; Spurlock, ME1
Astroug, H; Drenska, D; Kassarova, M; Mitcheva, M; Popov, A1
Kovac, G; Mertens, M; Mudron, P; Rehage, J; Sallmann, HP; Scholz, H1
Kobayashi, T; Okuyama, H; Watanabe, S; Yasuda, S1
Mudron, P; Qualmann, K; Rehage, J; Sallmann, HP; Scholz, H1
Altomare, E; Grattagliano, I; Vendemiale, G1
Lavine, JE1
Andrade, RJ; García-Escaño, MD1
Jariwalla, RJ1
Dikdan, G; Koneru, B; Soltys, K1
Bischoff, A1
Polin, D; Wolford, JH1
Nesterovich, IaM1
Onodera, M; Sakurai, H; Toyama, T1
Biocca, ME; Canuto, RA; Dianzani, MU; Muzio, G1
Albano, E; Biasi, F; Carini, R; Chiarpotto, E; Dianzani, MU; Marinari, UM; Poli, G1
Becker, E; Berndt, J; Messner, B1
Faris, R; McLaren, DS; Zekian, B1
Dickie, MM; Hancock, RL1
Hirayama, C; Hiroshige, K1
Arvela, P1
Andrews, JW; Murai, T1
Garlich, JD; Hamilton, PB1
Witting, LA1
Murphy, D; Wolford, JH1
Di Luzio, NR1
Higgs, DJ; Levander, OA; Morris, VC; Varma, RN1
Kratzing, CC; Spratt, MG1
Braekkan, OR; Lambertsen, G; Njaa, LR; Utne, F1
Kakulas, BA; Milner, G1
Barnes, RH; Krook, L; Pond, WG; Reid, IM1
Bunyan, J; Cawthorne, MA; Diplock, AT; Green, J1
Ferruccio, S1
De la Iglesia, FA; Hartroft, WS; Porta, EA1
Kinsella, JE1
Borgman, RF1

Reviews

22 review(s) available for d-alpha tocopherol and Liver Steatosis

ArticleYear
[Fibrosis in chronic hepatitis C infection: mechanisms and cofactors].
    Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2

    Topics: Adult; Age Factors; Aged; Alcoholism; alpha-Tocopherol; Antiviral Agents; Biopsy; Child; Cicatrix; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Female; Hemochromatosis; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunohistochemistry; Inflammation; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Necrosis; Phenotype; Risk Factors; Sex Factors; Transforming Growth Factor beta

2002
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
    Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1

    Topics: Bariatric Surgery; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Precision Medicine; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E; Weight Loss

2014
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
    Clinical and molecular hepatology, 2013, Volume: 19, Issue:4

    Topics: Alanine Transaminase; Alcohol Drinking; Antioxidants; Aspartate Aminotransferases; Elasticity Imaging Techniques; Energy Intake; Exercise; Fatty Liver; Humans; Liver Function Tests; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Risk Factors; Tomography, X-Ray Computed; Vitamin E

2013
Nonalcoholic fatty liver disease: a systematic review.
    JAMA, 2015, Jun-09, Volume: 313, Issue:22

    Topics: Alanine Transaminase; Biomarkers; Biopsy; Diabetes Complications; Diet Therapy; Exercise; Fatty Liver; Humans; Liver; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Risk Factors; Thiazolidinediones; Vitamin E

2015
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment.
    Clinical and molecular hepatology, 2016, Volume: 22, Issue:3

    Topics: Biomarkers; Chenodeoxycholic Acid; Clinical Trials as Topic; Fatty Liver; Fibrosis; Humans; Liver; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Tomography, X-Ray Computed; Ultrasonography; Vitamin E

2016
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48, Issue:5

    Topics: Acetylcysteine; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Child; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fatty Liver; Humans; Hypoglycemic Agents; Liver; Metformin; Pioglitazone; Probucol; Randomized Controlled Trials as Topic; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E

2009
Nonalcoholic fatty liver disease in children.
    Current opinion in clinical nutrition and metabolic care, 2011, Volume: 14, Issue:2

    Topics: Child; Diet; Exercise; Fatty Liver; Genetic Predisposition to Disease; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Vitamin E

2011
[Fatty liver and its clinical management in obese adolescents].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:1

    Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E

2011
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?
    Expert review of gastroenterology & hepatology, 2011, Volume: 5, Issue:2

    Topics: Animals; Fatty Liver; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mitochondria, Liver; Mitochondrial Diseases; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Vitamin E

2011
Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.
    Nature reviews. Endocrinology, 2011, May-10, Volume: 7, Issue:8

    Topics: Diabetes Mellitus, Type 2; Fatty Liver; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Pioglitazone; Risk Factors; Thiazolidinediones; Treatment Outcome; Vitamin E; Weight Loss

2011
Vitamin E and nonalcoholic fatty liver disease.
    Current opinion in clinical nutrition and metabolic care, 2012, Volume: 15, Issue:6

    Topics: Alanine Transaminase; Animals; Antioxidants; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pioglitazone; Randomized Controlled Trials as Topic; Thiazolidinediones; Treatment Outcome; Vitamin E

2012
Nonalcoholic fatty liver disease: current issues and novel treatment approaches.
    Drugs, 2013, Volume: 73, Issue:1

    Topics: Carcinoma, Hepatocellular; Fatty Liver; Humans; Hypoglycemic Agents; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Pioglitazone; Randomized Controlled Trials as Topic; Thiazolidinediones; Vitamin E; Weight Loss

2013
Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
    Alternative medicine review : a journal of clinical therapeutic, 2002, Volume: 7, Issue:4

    Topics: Antioxidants; Betaine; Fatty Liver; Female; Humans; Insulin Resistance; Lipotropic Agents; Liver; Magnesium; Obesity; Oxidative Stress; Vitamin E

2002
Lipids and lipid-activated vitamins in chronic cholestatic diseases.
    Clinics in liver disease, 1998, Volume: 2, Issue:2

    Topics: Avitaminosis; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Fatty Liver; Humans; Lipid Metabolism; Liver Cirrhosis, Biliary; Malabsorption Syndromes; Vitamin A; Vitamin D; Vitamin E; Vitamin K; Vitamins

1998
[Treatment of nonalcoholic steatohepatitis (NASH)].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2004, Volume: 101, Issue:11

    Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Liver Transplantation; Obesity; Oleanolic Acid; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E

2004
Review article: Drug therapy for non-alcoholic fatty liver disease.
    Alimentary pharmacology & therapeutics, 2006, Jan-15, Volume: 23, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Betaine; Cholagogues and Choleretics; Enzyme Inhibitors; Fatty Liver; Humans; Hypoglycemic Agents; Lipotropic Agents; Metformin; Pentoxifylline; Probucol; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E

2006
New treatments for nonalcoholic fatty liver disease.
    Current gastroenterology reports, 2006, Volume: 8, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antioxidants; Caloric Restriction; Exercise; Fatty Liver; Fibrosis; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Obesity; Oxidative Stress; Thiazolidinediones; Vitamin E; Weight Loss

2006
Therapy of NAFLD: antioxidants and cytoprotective agents.
    Journal of clinical gastroenterology, 2006, Volume: 40 Suppl 1

    Topics: Acetylcysteine; Antioxidants; Betaine; Cholagogues and Choleretics; Disease Progression; Fatty Liver; Humans; Lipid Peroxidation; S-Adenosylmethionine; Ursodeoxycholic Acid; Vitamin E

2006
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Randomized Controlled Trials as Topic; Vitamin E; Vitamins

2007
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    The Journal of nutritional biochemistry, 2007, Volume: 18, Issue:3

    Topics: Betaine; Cytokines; Dietary Supplements; Environmental Exposure; Fatty Liver; Female; Humans; Insulin Resistance; Life Style; Liver; Liver Cirrhosis; Metabolic Syndrome; Methionine; Middle Aged; Mitochondrial Diseases; Oxidative Stress; S-Adenosylmethionine; United States; Vitamin E; Xenobiotics; Zinc

2007
Diet and nonalcoholic fatty liver disease.
    Current opinion in lipidology, 2008, Volume: 19, Issue:1

    Topics: Clinical Trials as Topic; Dietary Fats; Fatty Liver; Fish Oils; Humans; Vitamin E; Weight Loss

2008
Rice-bran products: phytonutrients with potential applications in preventive and clinical medicine.
    Drugs under experimental and clinical research, 2001, Volume: 27, Issue:1

    Topics: Animals; Anticholesteremic Agents; Coumaric Acids; Dietary Fiber; Fatty Liver; Free Radical Scavengers; Heart Diseases; Hyperlipidemias; Inositol; Kidney Calculi; Neoplasms; Oryza; Phytosterols; Plant Extracts; Plant Oils; Rice Bran Oil; Triterpenes; Vitamin E

2001

Trials

28 trial(s) available for d-alpha tocopherol and Liver Steatosis

ArticleYear
Vitamin E sequestration by liver fat in humans.
    JCI insight, 2020, 01-16, Volume: 5, Issue:1

    Topics: Adolescent; Adult; alpha-Tocopherol; Cell Line; Fatty Liver; Female; Hep G2 Cells; Humans; Kinetics; Lipids; Lipoproteins; Liver; Obesity; Vitamin E; Young Adult

2020
Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial.
    Nutrition journal, 2013, Dec-27, Volume: 12, Issue:1

    Topics: Adult; Aged; Alanine Transaminase; alpha-Tocopherol; Apolipoproteins B; Aspartate Aminotransferases; C-Reactive Protein; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Nutrition Assessment; Prospective Studies; Risk Factors; Tocotrienols; Triglycerides; Ultrasonography

2013
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1

    Topics: Adolescent; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Blood Glucose; Body Weight; Child; Diet, Reducing; Double-Blind Method; Exercise Therapy; Fasting; Fatty Liver; Female; Humans; Insulin; Insulin Resistance; Life Style; Lipids; Liver; Male; Time Factors; Transaminases; Treatment Outcome

2008
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:10

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; alpha-Tocopherol; Aspartate Aminotransferases; Body Weight; Cholesterol; Fatty Liver; Female; gamma-Glutamyltransferase; Hepatitis; Humans; Liver Cirrhosis; Male; Pilot Projects; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triglycerides

2001
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2018, Volume: 29, Issue:2

    Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Biomarkers; Dietary Supplements; Double-Blind Method; Fatty Liver; Female; Humans; Inflammation; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pilot Projects; Treatment Outcome; Vitamin E

2018
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.
    Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:2

    Topics: Adult; Alanine Transaminase; Antioxidants; Fatty Liver; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Thiazolidinediones; Vitamin E; Weight Loss

2013
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.
    Contemporary clinical trials, 2009, Volume: 30, Issue:1

    Topics: Antioxidants; Double-Blind Method; Fatty Liver; Humans; Hypoglycemic Agents; Pioglitazone; Research Design; Thiazolidinediones; Vitamin E

2009
Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
    Gastroenterology, 2008, Volume: 135, Issue:6

    Topics: Adolescent; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Biopsy; Child; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Hematocrit; Humans; Hypoglycemic Agents; Leukocyte Count; Liver; Male; Metformin; Predictive Value of Tests; Prevalence; Prognosis; Prospective Studies; ROC Curve; Severity of Illness Index; Vitamin E

2008
Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:8

    Topics: Adipokines; Adult; Aged; Antioxidants; Apoptosis; Cholic Acids; Cytoprotection; Drug Therapy, Combination; Fatty Liver; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Treatment Outcome; Vitamin E; Young Adult

2009
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
    Contemporary clinical trials, 2010, Volume: 31, Issue:1

    Topics: Adolescent; Alanine Transaminase; Child; Double-Blind Method; Fatty Liver; Female; Humans; Hypoglycemic Agents; Liver Function Tests; Male; Metformin; Patient Selection; Research Design; Vitamin E

2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
    The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18

    Topics: Adult; Antioxidants; Chi-Square Distribution; Double-Blind Method; Fatty Liver; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Intention to Treat Analysis; Liver; Male; Middle Aged; Pioglitazone; Thiazolidinediones; Transaminases; Vitamin E; Weight Gain

2010
Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2011, Volume: 12, Issue:4

    Topics: Animals; Fatty Liver; Female; Humans; Insulin Resistance; Male; Mice; Middle Aged; Mineralocorticoid Receptor Antagonists; Non-alcoholic Fatty Liver Disease; Spironolactone; Vitamin E

2011
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
    JAMA, 2011, Apr-27, Volume: 305, Issue:16

    Topics: Adolescent; Alanine Transaminase; Antioxidants; Child; Double-Blind Method; Fatty Liver; Female; Humans; Hypoglycemic Agents; Male; Metformin; Non-alcoholic Fatty Liver Disease; Obesity; Severity of Illness Index; Treatment Outcome; Vitamin E

2011
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Free radical biology & medicine, 2012, May-01, Volume: 52, Issue:9

    Topics: Body Mass Index; Fatty Liver; Humans; Phosphatidylcholines; Romania; Silybin; Silymarin; Vitamin E

2012
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
    Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:4

    Topics: Adipose Tissue; Adult; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatty Liver; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Reference Values; Thiazolidinediones; Time Factors; Treatment Outcome; Vitamin E

2012
Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E.
    Free radical research, 2013, Volume: 47, Issue:3

    Topics: Body Mass Index; Child; Diet; Exercise Therapy; Fatty Liver; Female; Humans; Life Style; Lipids; Male; Obesity; Oxidative Stress; Vitamin E

2013
Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Hepato-gastroenterology, 2012, Volume: 59, Issue:119

    Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Antioxidants; Aspartate Aminotransferases; Bilirubin; Biomarkers; Blood Glucose; Blood Pressure; Chi-Square Distribution; Chlorella vulgaris; Drug Therapy, Combination; Fatty Liver; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Iran; Male; Metformin; Middle Aged; Non-alcoholic Fatty Liver Disease; Plant Preparations; Serum Albumin; Serum Albumin, Human; Time Factors; Treatment Outcome; Triglycerides; Uric Acid; Vitamin E; Weight Loss

2012
Management of nonalcoholic steatohepatitis: an analytic review.
    Journal of clinical gastroenterology, 2002, Volume: 35, Issue:3

    Topics: Diabetes Mellitus; Fatty Liver; Hepatitis; Humans; Hyperinsulinism; Iron; Leptin; Liver Transplantation; Risk Factors; Silymarin; Triglycerides; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid; Vitamin E

2002
Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
    Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:2

    Topics: Adult; Antioxidants; Cytokines; Exercise; Fatty Liver; Female; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Pilot Projects; Risk Reduction Behavior; Tumor Necrosis Factor-alpha; Vitamin E; Weight Loss

2003
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:11

    Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Biopsy, Needle; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Treatment Outcome; Vitamin E

2003
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:12

    Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Logistic Models; Male; Middle Aged; Pilot Projects; Pioglitazone; Prospective Studies; Thiazolidinediones; Treatment Outcome; Vitamin E

2004
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:5

    Topics: Adult; Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Biopsy; Body Mass Index; Diet, Reducing; Fatty Liver; Female; Follow-Up Studies; Hepatitis; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Metformin; Middle Aged; Treatment Outcome; Vitamin E

2005
[Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
    Minerva gastroenterologica e dietologica, 2005, Volume: 51, Issue:2

    Topics: Adult; Aged; Biomarkers; Drug Combinations; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silymarin; Vitamin E

2005
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:3

    Topics: Administration, Oral; Adult; Alanine Transaminase; Alkaline Phosphatase; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combination; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Male; Middle Aged; Oxidative Stress; Prospective Studies; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid; Vitamin E

2005
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.
    Gut, 2006, Volume: 55, Issue:6

    Topics: Drug Combinations; Fatty Liver; Humans; Insulin Resistance; Phospholipids; Silybin; Silymarin; Vitamin E

2006
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease.
    Alimentary pharmacology & therapeutics, 2006, Volume: 24, Issue:11-12

    Topics: Adolescent; Alanine Transaminase; Antioxidants; Ascorbic Acid; Blood Glucose; Child; Child, Preschool; Fatty Liver; Female; Humans; Insulin Resistance; Male; Treatment Outcome; Vitamin E

2006
Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children.
    World journal of gastroenterology, 2008, Mar-14, Volume: 14, Issue:10

    Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; China; Diet, Reducing; Exercise; Fatty Liver; Female; Humans; Insulin Resistance; Life Style; Liver; Male; Obesity; Single-Blind Method; Vitamin E

2008
Effect of dietary protein and selected antioxidants on fatty liver hemorrhagic syndrome induced in Japanese quail.
    Poultry science, 1993, Volume: 72, Issue:11

    Topics: Animals; Coturnix; Dietary Proteins; Fatty Liver; Female; Glutathione; Hemorrhage; Organ Size; Oviposition; Poultry Diseases; Vitamin E

1993

Other Studies

110 other study(ies) available for d-alpha tocopherol and Liver Steatosis

ArticleYear
α-Tocopherol reduces VLDL secretion through modulation of intracellular ER-to-Golgi transport of VLDL.
    Canadian journal of physiology and pharmacology, 2023, Nov-01, Volume: 101, Issue:11

    Topics: alpha-Tocopherol; Endoplasmic Reticulum; Fatty Liver; Humans; Lipoproteins, VLDL; Liver; Transport Vesicles; Triglycerides

2023
Role of dietary α- and γ-tocopherol from Rosa mosqueta oil in the prevention of alterations induced by high-fat diet in a murine model.
    Nutrition (Burbank, Los Angeles County, Calif.), 2018, Volume: 53

    Topics: alpha-Tocopherol; Animals; Diet, High-Fat; Disease Models, Animal; Fatty Liver; gamma-Tocopherol; Inflammation; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Plant Oils; Rosa

2018
Role of Borage Seed Oil and Fish Oil with or without Turmeric and Alpha- Tocopherol in Prevention of Cardiovascular Disease and Fatty Liver in Rats.
    Journal of oleo science, 2018, Dec-01, Volume: 67, Issue:12

    Topics: alpha-Tocopherol; Animals; Antioxidants; Borago; Cardiovascular Diseases; Curcuma; Curcumin; Dietary Supplements; Dyslipidemias; Fatty Acids, Unsaturated; Fatty Liver; Fish Oils; Liver; Male; Metabolic Syndrome; Myocardium; Plant Oils; Rats, Sprague-Dawley; Seeds

2018
[Redox status parameters in adolescent-mongoloids with exogenously constitutional obesity and fatty hepatosis].
    Voprosy pitaniia, 2018, Volume: 87, Issue:5

    Topics: Adolescent; alpha-Tocopherol; Antioxidants; Asian People; Erythrocytes; Fatty Liver; Glutathione Disulfide; Humans; Lipid Peroxidation; Male; Obesity; Vitamin A

2018
Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: alpha-Tocopherol; Animals; Disease Models, Animal; Fat Emulsions, Intravenous; Fatty Liver; Fish Oils; Mice, Inbred C57BL; Parenteral Nutrition; Phytosterols; Protective Agents; Soybean Oil

2019
Effect of carnosine alone or combined with α-tocopherol on hepatic steatosis and oxidative stress in fructose-induced insulin-resistant rats.
    Journal of physiology and biochemistry, 2014, Volume: 70, Issue:2

    Topics: alpha-Tocopherol; Animals; Body Weight; Carnosine; Fatty Liver; Fructose; Insulin Resistance; Liver; Male; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley

2014
Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats.
    European journal of nutrition, 2017, Volume: 56, Issue:1

    Topics: Adipose Tissue; alpha-Tocopherol; Animals; Anti-Inflammatory Agents; Body Composition; Cardiovascular System; Diet, High-Fat; Dietary Carbohydrates; Fatty Liver; Insulin Resistance; Liver; Male; Metabolic Syndrome; Obesity, Abdominal; Organ Size; Rats; Rats, Wistar; Tocotrienols; Vitamin E

2017
Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease.
    Obesity surgery, 2010, Volume: 20, Issue:1

    Topics: Adult; Alanine Transaminase; alpha-Tocopherol; Aspartate Aminotransferases; Body Mass Index; Fatty Liver; Female; Humans; Linear Models; Male; Middle Aged; Obesity, Morbid; Ultrasonography; Vitamin A

2010
Children's toxicology from bench to bed--Liver Injury (2): Mechanism of antioxidant therapy for nonalcoholic fatty liver disease.
    The Journal of toxicological sciences, 2009, Volume: 34 Suppl 2

    Topics: alpha-Tocopherol; Animals; Antioxidants; Carrier Proteins; Choline Deficiency; Disease Models, Animal; Fatty Liver; Liver; Male; Methionine; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Vitamin E

2009
Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis.
    The Journal of nutritional biochemistry, 2010, Volume: 21, Issue:12

    Topics: Alanine Transaminase; alpha-Tocopherol; Animals; Antioxidants; Body Weight; Dietary Supplements; Fatty Liver; gamma-Tocopherol; Inflammation; Lipid Peroxidation; Lipopolysaccharides; Liver; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Triglycerides

2010
Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:2

    Topics: Adiponectin; alpha-Tocopherol; Animal Feed; Animals; Aryldialkylphosphatase; Blood Pressure; Fatty Liver; Fructose; Glutathione Reductase; Hypoglycemic Agents; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Male; Malondialdehyde; Metabolic Syndrome; Phospholipids; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2010
Dietary kakrol (Momordica dioica Roxb.) flesh inhibits triacylglycerol absorption and lowers the risk for development of fatty liver in rats.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:10

    Topics: alpha-Tocopherol; Animals; Cholesterol; Fatty Acids, Nonesterified; Fatty Liver; Feces; Fruit; Intestinal Absorption; Lipid Metabolism; Liver; Lymph; Male; Momordica; Phytotherapy; Rats; Rats, Sprague-Dawley; Risk Factors; Triglycerides

2011
Impact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol.
    Cardiovascular research, 2003, Jun-01, Volume: 58, Issue:3

    Topics: alpha-Tocopherol; Animals; Diet; Diglycerides; Echocardiography; Energy Metabolism; Fatty Acids; Fatty Liver; Hemodynamics; Hypertrophy, Left Ventricular; Lipids; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Models, Animal; Myocardium; Thiobarbituric Acid Reactive Substances

2003
[Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Ryumachi. [Rheumatism], 2003, Volume: 43, Issue:4

    Topics: alpha-Tocopherol; Antioxidants; Bezafibrate; Caloric Restriction; Diet, Reducing; Fatty Liver; Female; Humans; Inclusion Bodies; Lupus Erythematosus, Systemic; Middle Aged; Neutrophil Infiltration; Prednisolone; Treatment Outcome

2003
Role of oxidative stress in the increased activation of signal transducers and activators of transcription-3 in the fatty livers of obese Zucker rats.
    Surgery, 2004, Volume: 136, Issue:3

    Topics: alpha-Tocopherol; Animals; Antioxidants; DNA-Binding Proteins; Fatty Liver; Interleukin-6; Models, Animal; NF-kappa B; Oxidative Stress; Rats; Rats, Zucker; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transcriptional Activation

2004
Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
    Basic research in cardiology, 2001, Volume: 96, Issue:5

    Topics: alpha-Tocopherol; Animals; Antioxidants; Blood Pressure; Cardiomegaly; Carnitine; Energy Metabolism; Fatty Liver; Glutathione Peroxidase; Heart Rate; Lipid Peroxidation; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Myocardium; Organ Size; Oxidative Stress; Superoxide Dismutase; Tiopronin; Vitamin E

2001
In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model.
    Lipids in health and disease, 2018, Feb-05, Volume: 17, Issue:1

    Topics: Choline; Curcumin; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Drug Compounding; Drug Synergism; Fatty Liver; Hep G2 Cells; Humans; Lipid Peroxidation; Liver; Phosphatidylcholines; PPAR alpha; PPAR gamma; Silymarin; Vitamin E

2018
A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.
    World journal of gastroenterology, 2013, May-28, Volume: 19, Issue:20

    Topics: Animals; Biomarkers; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Glutathione; Glutathione Peroxidase; Keratin-18; Liver; Male; Malondialdehyde; Mitochondria, Liver; Mitochondrial Proteins; Nitroso Compounds; Oxidative Phosphorylation; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Silybin; Silymarin; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances; Thioredoxins; Time Factors; Tyrosine; Vitamin E

2013
Long-term (>=2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis.
    Hepato-gastroenterology, 2013, Volume: 60, Issue:126

    Topics: Aged; Aged, 80 and over; Alanine Transaminase; Antioxidants; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Time Factors; Vitamin E

2013
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Journal of the Academy of Nutrition and Dietetics, 2014, Volume: 114, Issue:8

    Topics: Adult; Aged; Ascorbic Acid; Body Mass Index; Canada; Case-Control Studies; Cross-Sectional Studies; Diet Records; Dietary Fats; Energy Intake; Fatty Liver; Female; Guidelines as Topic; Healthy Volunteers; Humans; Insulin Resistance; Male; Middle Aged; Motor Activity; Non-alcoholic Fatty Liver Disease; Nutrition Assessment; Prospective Studies; Sodium, Dietary; Vitamin D; Vitamin E; Young Adult

2014
The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response.
    Hepatology (Baltimore, Md.), 2016, Volume: 63, Issue:3

    Topics: Animals; Carotid Artery Diseases; Fatty Liver; Female; Hedgehog Proteins; Humans; Lipase; Lipoproteins, VLDL; Liver; Male; Membrane Proteins; Non-alcoholic Fatty Liver Disease; Vitamin E; Vitamins

2016
Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
    World journal of gastroenterology, 2016, Jul-14, Volume: 22, Issue:26

    Topics: Animals; Antioxidants; Blotting, Western; Carnitine O-Palmitoyltransferase; Catalase; Cell Line, Tumor; Cells, Cultured; Fatty Liver; Fluorometry; Hepatocytes; Lipid Droplets; Lipid Metabolism; Lipid Peroxidation; Microscopy, Fluorescence; NF-kappa B; Oleic Acid; Oxidative Stress; Palmitates; Peroxisome Proliferator-Activated Receptors; Rats; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Silybin; Silymarin; Spectrophotometry; Sterol Regulatory Element Binding Protein 1; Triglycerides; Vitamin E

2016
Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.
    Scandinavian journal of gastroenterology, 2008, Volume: 43, Issue:1

    Topics: Adult; Aged; Aldehydes; Diet; Dietary Carbohydrates; Dietary Fats; Erythrocytes; Fatty Liver; Female; Glutathione Peroxidase; Glutathione Reductase; Guanosine; Humans; Male; Middle Aged; Oxidative Stress; Vitamin E

2008
Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat.
    European journal of pharmacology, 2009, Feb-14, Volume: 604, Issue:1-3

    Topics: Animals; Antioxidants; Blotting, Western; Body Weight; Disease Models, Animal; Fatty Liver; Lipid Peroxidation; Liver; Male; Metformin; Rats; Rats, Sprague-Dawley; Vitamin E

2009
Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
    Scandinavian journal of gastroenterology, 2009, Volume: 44, Issue:9

    Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; Blotting, Western; Cyclooxygenase 2; Fatty Liver; Genes, bcl-2; Inflammation; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Triazoles; Vitamin E

2009
Chronic acetonemia alters liver oxidative balance and lipid content in rats. A model of NASH?
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:1

    Topics: Acetone; Animals; Blood Glucose; Cholesterol; Chronic Disease; Disease Models, Animal; Fatty Liver; Glutathione; Ketone Bodies; Ketosis; Lipid Metabolism; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Solvents; Thiobarbituric Acid Reactive Substances; Triglycerides; Vitamin E

2010
Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion.
    Transplantation proceedings, 2009, Volume: 41, Issue:10

    Topics: Animals; Blotting, Northern; DNA Damage; DNA, Mitochondrial; Fatty Liver; Glutathione; Ion Channels; Leptin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mitochondrial Proteins; Reperfusion Injury; RNA, Messenger; Succinates; Uncoupling Protein 2; Vitamin E

2009
Low-carbohydrate and high-fat diets on the promotion of hepatic steatosis in rats.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:10

    Topics: Animals; Body Weight; Caseins; Diet, Carbohydrate-Restricted; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Fatty Liver; Glutathione; Hyperglycemia; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Severity of Illness Index; Vitamin E

2010
Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:5

    Topics: Cardiovascular Diseases; Fatty Liver; Humans; Randomized Controlled Trials as Topic; Vitamin E

2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
    The New England journal of medicine, 2010, 09-16, Volume: 363, Issue:12

    Topics: Antioxidants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Fatty Liver; Humans; Meta-Analysis as Topic; Vitamin E

2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
    The New England journal of medicine, 2010, 09-16, Volume: 363, Issue:12

    Topics: Antioxidants; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oxidative Stress; Vitamin E

2010
On the mechanism of action of vitamin E for nonalcoholic steatohepatitis.
    Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3

    Topics: Antioxidants; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Vitamin E

2011
Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance.
    Journal of diabetes, 2009, Volume: 1, Issue:4

    Topics: Animals; Ascorbic Acid; Body Weight; Cholesterol; Fatty Liver; Genistein; Glutathione Peroxidase; Glutathione Reductase; Insulin; Insulin Resistance; Interleukin-6; Liver; Liver Function Tests; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Phospholipids; Phytoestrogens; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Vitamin E

2009
Antioxidative and hepatoprotective effects of fructo-oligosaccharide in d-galactose-treated Balb/cJ mice.
    The British journal of nutrition, 2011, Volume: 105, Issue:6

    Topics: Aging, Premature; Alanine Transaminase; Animals; Antioxidants; Bacterial Load; Bifidobacterium; Disease Models, Animal; Fatty Liver; Feces; Fermentation; Galactose; Lactobacillus; Liver; Male; Mice; Mice, Inbred BALB C; Oligosaccharides; Oxidative Stress; Prebiotics; Triglycerides; Vitamin E

2011
[Influence of genipin and vitamin E on UCP2 and other correlation factors in non-alcoholic fatty liver disease].
    Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2010, Volume: 27, Issue:6

    Topics: Cell Line; Drug Synergism; Fatty Liver; Humans; Ion Channels; Iridoid Glycosides; Iridoids; Liver; Membrane Potential, Mitochondrial; Mitochondrial Proteins; NF-kappa B; Non-alcoholic Fatty Liver Disease; Protective Agents; RNA, Messenger; Tumor Necrosis Factor-alpha; Uncoupling Protein 2; Vitamin E

2010
Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH).
    European journal of medical research, 2011, Feb-24, Volume: 16, Issue:2

    Topics: Antioxidants; Carotenoids; Fatty Liver; Female; Humans; Male; Middle Aged; Oxidative Stress; Vitamin E

2011
Does vitamin E cure nonalcoholic steatohepatitis?
    Expert review of gastroenterology & hepatology, 2011, Volume: 5, Issue:2

    Topics: Dietary Supplements; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Vitamin E

2011
Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way?
    Nature reviews. Gastroenterology & hepatology, 2011, Jul-12, Volume: 8, Issue:8

    Topics: Adolescent; Alanine Transaminase; Child; Fatty Liver; Humans; Life Style; Metformin; Non-alcoholic Fatty Liver Disease; Treatment Outcome; Vitamin E

2011
Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.
    Toxicologic pathology, 2011, Volume: 39, Issue:7

    Topics: Adipose Tissue; Animals; Antineoplastic Agents; Body Weight; Cell Growth Processes; Cell Hypoxia; Cell Line; Chromans; Drinking; Endothelial Cells; Fatty Liver; Female; Gene Expression Regulation; Gene Regulatory Networks; Hemangiosarcoma; Hepatocytes; Histocytochemistry; Insulin-Like Growth Factor I; Liver; Mice; Organ Size; Oxidative Stress; PPAR gamma; Reproducibility of Results; Thiazolidinediones; Troglitazone; Vitamin E

2011
Vitamin E for nonalcoholic fatty liver disease.
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2011, Volume: 26, Issue:5

    Topics: Animals; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Vitamin E; Vitamins

2011
Medical therapy for nonalcoholic fatty liver disease in children and adolescents.
    Expert review of gastroenterology & hepatology, 2012, Volume: 6, Issue:1

    Topics: Adolescent; Biopsy; Child; Fatty Liver; Humans; Hypoglycemic Agents; Liver; Metformin; Non-alcoholic Fatty Liver Disease; Vitamin E; Vitamins

2012
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results.
    Clinics and research in hepatology and gastroenterology, 2012, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Fatty Liver; Humans; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Time Factors; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E; Vitamins; Young Adult

2012
Uric acid as a surrogate for fructose intake is not supported.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 54, Issue:3

    Topics: Diet; Fatty Liver; Female; Humans; Liver; Male; Uric Acid; Vitamin E; Vitamin E Deficiency

2012
Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
    Journal of pediatric gastroenterology and nutrition, 2012, Volume: 54, Issue:1

    Topics: Adolescent; Ascorbic Acid; Child; Cross-Sectional Studies; Diet; Dietary Sucrose; Energy Intake; Fatty Liver; Female; Fructose; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Nutrition Assessment; Prospective Studies; Surveys and Questionnaires; Uric Acid; Vitamin E; Vitamin E Deficiency; Vitamins

2012
[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis].
    Ugeskrift for laeger, 2012, Feb-20, Volume: 174, Issue:8

    Topics: Fatty Liver; Humans; Hypoglycemic Agents; Liver Cirrhosis; Liver Neoplasms; Pioglitazone; Prognosis; Risk Factors; Thiazolidinediones; Vitamin E

2012
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:6

    Topics: Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Metformin; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Thiazolidinediones; Vitamin E

2012
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:6

    Topics: Alcohol Drinking; Bariatric Surgery; Biopsy; Child; Disease Management; Fatty Liver; Fatty Liver, Alcoholic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Incidence; Liver Cirrhosis; Mass Screening; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; United States; Vitamin E; Weight Loss

2012
Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
    International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 2011, Volume: 81, Issue:6

    Topics: Adiponectin; Adolescent; Cholesterol, LDL; Fatty Liver; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Non-alcoholic Fatty Liver Disease; Obesity; Tumor Necrosis Factor-alpha; Vitamin E

2011
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
    Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:6

    Topics: Combined Modality Therapy; Cost-Benefit Analysis; Fatty Liver; Humans; Hypoglycemic Agents; Life Style; Liver Cirrhosis; Markov Chains; Non-alcoholic Fatty Liver Disease; Pioglitazone; Quality-Adjusted Life Years; Severity of Illness Index; Thiazolidinediones; Vitamin E; Vitamins

2012
Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH).
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Adult; Biomarkers; Fatty Liver; Female; Humans; Male; Metabolome; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Prognosis; Treatment Outcome; Vitamin E

2012
Bibliography. Micronutrients. Current world literature.
    Current opinion in clinical nutrition and metabolic care, 2012, Volume: 15, Issue:6

    Topics: Calcium, Dietary; Dietary Supplements; Fatty Liver; Fractures, Bone; Humans; Inflammation; Inflammatory Bowel Diseases; Iron; Micronutrients; Non-alcoholic Fatty Liver Disease; Nutritional Physiological Phenomena; Trace Elements; Vitamin D; Vitamin E; Vitamin K

2012
Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States.
    Gastroenterology, 2003, Volume: 124, Issue:7

    Topics: Alanine Transaminase; Antioxidants; Ascorbic Acid; Carotenoids; Fatty Liver; Humans; Iron; Liver; United States; Vitamin E

2003
[Action of vitamin E on liver steatosis due to phosphorus].
    Archivio italiano di scienze farmacologiche, 1952, Volume: 2, Issue:3

    Topics: Fatty Liver; Humans; Liver Diseases; Phosphorus; Phosphorus, Dietary; Vitamin E

1952
Experimental dietary cirrhosis.
    The Indian journal of medical research, 1962, Volume: 50

    Topics: Animals; Choline; Cystine; Diet; Fatty Liver; Humans; Liver Cirrhosis, Experimental; Methionine; Orotic Acid; Protein Deficiency; Siderosis; Vitamin E

1962
INHIBITION OF THE ETHANOL AND CARBON TETRACHLORIDE INDUCED FATTY LIVER BY ANTIOXIDANTS.
    Experimental and molecular pathology, 1965, Volume: 4

    Topics: Aniline Compounds; Antioxidants; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Ethanol; Fatty Liver; Glycerides; Pharmacology; Rats; Research; Toxicology; Vitamin E

1965
Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:11

    Topics: Antioxidants; Ascorbic Acid; Fatty Liver; Female; Hepatitis; Humans; Male; Prognosis; Risk Assessment; Treatment Outcome; Vitamin E

2003
Vitamin E therapy in patients with NASH.
    Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:2

    Topics: Alanine Transaminase; Antioxidants; Fatty Liver; Humans; Vitamin E

2004
More on vitamin E therapy.
    Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:2

    Topics: Antioxidants; Fatty Liver; Humans; Vitamin E

2004
The role of vitamin E and C therapy in NASH.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:9

    Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Biopsy, Needle; Dietary Supplements; Fatty Liver; Female; Humans; Liver Cirrhosis; Male; Probability; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vitamin E

2004
Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2004, Volume: 2, Issue:12

    Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Fatty Liver; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Pioglitazone; Thiazolidinediones; Vitamin E

2004
Treatment for NASH: the value of histology.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:1

    Topics: Antioxidants; Cholagogues and Choleretics; Fatty Liver; Hepatitis; Humans; Transaminases; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E

2005
[Drug therapy for nonalcoholic fatty liver disease].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:2

    Topics: Antioxidants; Fatty Liver; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Quaternary Ammonium Compounds; Vitamin E

2005
Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
    Medical hypotheses, 2006, Volume: 66, Issue:3

    Topics: Ascorbic Acid; Biopsy; Fatty Liver; Hepatitis; Humans; Liver; Transaminases; Ursodeoxycholic Acid; Vitamin E

2006
Blood oxidative stress markers are unreliable markers of hepatic steatosis.
    Alimentary pharmacology & therapeutics, 2006, Jan-01, Volume: 23, Issue:1

    Topics: Adult; Biomarkers; Cholesterol; Fatty Liver; Female; Glutathione Peroxidase; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oxidative Stress; Selenium; Superoxide Dismutase; Vitamin E

2006
Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.
    Journal of pediatric gastroenterology and nutrition, 2006, Volume: 42, Issue:2

    Topics: Adolescent; Antioxidants; Child; Clinical Trials as Topic; Data Collection; Fatty Liver; Female; Humans; Hypoglycemic Agents; Male; Metformin; Obesity; Vitamin E

2006
Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
    The American journal of gastroenterology, 2006, Volume: 101, Issue:6

    Topics: Adult; Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Biopsy; Body Mass Index; Diet, Reducing; Fatty Liver; Female; Hepatitis; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Metformin; Middle Aged; Treatment Outcome; Vitamin E

2006
Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
    Internal medicine journal, 2007, Volume: 37, Issue:4

    Topics: Fatty Liver; Humans; Insulin Resistance; Oxidants; Oxidative Stress; Pilot Projects; PPAR alpha; Vitamin E

2007
The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:9

    Topics: Adult; Aged; Antioxidants; Cytokines; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silybum marianum; Silymarin; Time Factors; Transaminases; Treatment Outcome; Ultrasonography; Vitamin E

2007
Is vitamin E beneficial in chronic liver disease?
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:2

    Topics: Animals; Chronic Disease; Fatty Liver; Glycochenodeoxycholic Acid; Oxidative Stress; Rats; Reactive Oxygen Species; Vitamin E

2007
Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:8 Pt 2

    Topics: Adolescent; Antioxidants; Child; Child, Preschool; Collagen Type VI; Fatty Liver; Female; Glutathione; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Oxidative Stress; Proteins; Vitamin E

2008
The influence of methionine, selenomethionine, and vitamin E on liver metabolic pathways and steatosis in high-cholesterol fed rabbits.
    Biological trace element research, 2007,Winter, Volume: 120, Issue:1-3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholesterol; Cholesterol, Dietary; Fatty Liver; Fructose-Bisphosphate Aldolase; Glutamate Dehydrogenase; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Liver; Male; Methionine; Rabbits; Selenomethionine; Triglycerides; Vitamin E

2007
Therapy for nonalcoholic fatty liver disease.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:4

    Topics: Animals; Antioxidants; Cholagogues and Choleretics; Disease Models, Animal; Fatty Liver; Glycine; Humans; Hypolipidemic Agents; Insulin Resistance; Liver; Mice; Oxazoles; Peroxisome Proliferator-Activated Receptors; Rats; Thiazolidinediones; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E

2008
Role of lipid peroxidation in the pathogenesis of the ethanol-induced fatty liver.
    Federation proceedings, 1967, Volume: 26, Issue:5

    Topics: Aniline Compounds; Animals; Antioxidants; Ethanol; Fatty Liver; Female; In Vitro Techniques; Liver; Rats; Triglycerides; Vitamin E

1967
[Clinical aspects of essential fatty acids].
    Saishin igaku. Modern medicine, 1967, Volume: 22, Issue:8

    Topics: Animals; Cell Membrane Permeability; Cholesterol; Coronary Disease; Fatty Acids, Essential; Fatty Liver; Humans; Linoleic Acids; Liver Cirrhosis; Liver Diseases; Malabsorption Syndromes; Nutrition Disorders; Proteins; Rats; Vitamin E

1967
Effect of selected dietary antioxidants on fatty liver-haemorrhagic syndrome in laying hens.
    British poultry science, 1994, Volume: 35, Issue:4

    Topics: Animals; Antioxidants; Ascorbic Acid; Chickens; Cysteine; Fatty Liver; Female; Food, Fortified; Glutathione; Hemorrhage; Liver; Oviposition; Poultry Diseases; Syndrome; Vitamin E

1994
Biochemical and morphological studies on the effects of anthocyans and vitamin E on carbon tetrachloride induced liver injury.
    Cellular and molecular biology (Noisy-le-Grand, France), 1993, Volume: 39, Issue:4

    Topics: Alanine Transaminase; Animals; Anthocyanins; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug Synergism; Fatty Liver; Glutathione; Lipid Peroxidation; Male; Oxidation-Reduction; Rats; Rats, Wistar; Vitamin E

1993
Plasma and liver alpha-tocopherol in dairy cows with left abomasal displacement and fatty liver.
    Zentralblatt fur Veterinarmedizin. Reihe A, 1997, Volume: 44, Issue:2

    Topics: 3-Hydroxybutyric Acid; Abomasum; Animals; Blood Glucose; Cattle; Cattle Diseases; Fatty Acids, Nonesterified; Fatty Liver; Female; Glutamate Dehydrogenase; Glycogen; Hydroxybutyrates; Lipid Metabolism; Lipid Peroxidation; Liver; Malondialdehyde; Transaminases; Triglycerides; Vitamin E

1997
Effects of dietary unsaturated fatty acid and chronic carbon tetrachloride treatment on the accumulation of oxidation products, alpha-tocopherol and liver injury in mice.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:10

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Diet; Drug Administration Schedule; Drug Interactions; Fatty Acids, Unsaturated; Fatty Liver; Female; Lipid Peroxidation; Liver; Mice; Mice, Inbred ICR; Oxidation-Reduction; Phospholipids; Proteins; Thiobarbituric Acid Reactive Substances; Triglycerides; Vitamin E

1998
A study of lipid peroxidation and vitamin E in dairy cows with hepatic insufficiency.
    Zentralblatt fur Veterinarmedizin. Reihe A, 1999, Volume: 46, Issue:4

    Topics: Animals; Cattle; Cattle Diseases; Fatty Liver; Female; Lipid Peroxidation; Liver; Liver Failure, Acute; Postpartum Period; Vitamin E

1999
An update on the role of free radicals and antioxidant defense in human disease.
    International journal of clinical & laboratory research, 1999, Volume: 29, Issue:2

    Topics: Aging; Alcoholism; Antioxidants; Arteriosclerosis; Diabetes Mellitus; Disease; Fatty Liver; Free Radicals; Glutathione; Humans; Ischemia; Lipid Peroxidation; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Vitamin E

1999
Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
    The Journal of pediatrics, 2000, Volume: 136, Issue:6

    Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; Fatty Liver; Female; Humans; Male; Obesity; Pilot Projects; Vitamin E

2000
[Fatty liver].
    Medicina clinica, 2000, Apr-22, Volume: 114, Issue:15

    Topics: Adult; Antioxidants; Cholagogues and Choleretics; Cross-Sectional Studies; Diabetes Complications; Fatty Liver; Fatty Liver, Alcoholic; Humans; Logistic Models; Male; Middle Aged; Obesity; Pilot Projects; Prognosis; Risk Factors; Spain; Ultrasonography; Ursodeoxycholic Acid; Vitamin E

2000
Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:1

    Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Fatty Liver; Glutathione; Glutathione Peroxidase; Hot Temperature; Ischemia; Liver; Male; Obesity; Oxidative Stress; Rats; Rats, Zucker; Superoxide Dismutase; Vitamin E

2001
[Fatty liver and raised gamma-GT: it can happen to abstainers, too].
    MMW Fortschritte der Medizin, 2002, Feb-14, Volume: 144, Issue:7

    Topics: Cholagogues and Choleretics; Clinical Enzyme Tests; Diabetes Complications; Diagnosis, Differential; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Hypoglycemic Agents; Male; Metformin; Obesity; Risk Factors; Ursodeoxycholic Acid; Vitamin E

2002
Effect of inositol, lecithin, vitamins (B12 with choline and E), and iodinated casein on induced fatty liver-hemorrhagic syndrome in laying chickens.
    Poultry science, 1975, Volume: 54, Issue:4

    Topics: Animal Feed; Animals; Caseins; Chickens; Choline; Eggs; Fatty Liver; Female; Hemorrhage; Inositol; Iodine; Lipids; Lipotropic Agents; Liver; Oviposition; Phosphatidylcholines; Poultry Diseases; Syndrome; Vitamin B 12; Vitamin E; Vitamins

1975
[Use of vitamin E for treatment of experimental liver dystrophy].
    Vrachebnoe delo, 1976, Issue:6

    Topics: Acute Disease; Animals; Drug Evaluation; Fatty Liver; Female; Liver Cirrhosis, Experimental; Liver Diseases; Rats; Vitamin E

1976
[Fatty liver caused by carbon disulfide and protective effect of vitamin E].
    Nihon eiseigaku zasshi. Japanese journal of hygiene, 1975, Volume: 30, Issue:1

    Topics: Animals; Carbon Disulfide; Fatty Liver; Male; Rats; Vitamin E

1975
[Current biochemical, clinical and therapeutic views on the subject of liver steatosis].
    La Clinica terapeutica, 1975, Apr-15, Volume: 73, Issue:1

    Topics: Adenosine Triphosphate; Choline; Fatty Liver; Humans; Triglycerides; Vitamin B Complex; Vitamin E

1975
Lipid peroxidation in fatty liver induced by caffeine in rats.
    International journal of tissue reactions, 1991, Volume: 13, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Caffeine; Fatty Liver; Lipid Peroxidation; Male; Rats; Rats, Inbred F344; Triglycerides; Vitamin E

1991
Lipid peroxidation and haloalkylation in CCl4-induced liver fatty degeneration and necrosis.
    Basic life sciences, 1988, Volume: 49

    Topics: Alkaline Phosphatase; Alkylation; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride Poisoning; Fatty Liver; Lipid Peroxidation; Liver; Necrosis; Rats; Reference Values; Vitamin E

1988
Two mechanisms of CCl4-induced fatty liver: lipid peroxidation or covalent binding studied in cultured rat hepatocytes.
    Free radical research communications, 1987, Volume: 3, Issue:1-5

    Topics: Animals; Binding, Competitive; Carbon Tetrachloride; Cells, Cultured; Fatty Liver; Female; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, VLDL; Liver; Malondialdehyde; Phenobarbital; Piperonyl Butoxide; Rats; Rats, Inbred Strains; Vitamin E

1987
The liver during recovery from protein-calorie malnutrition.
    The Journal of tropical medicine and hygiene, 1968, Volume: 71, Issue:11

    Topics: Child, Preschool; Copper; Fats; Fatty Liver; Female; Humans; Infant; Iron; Kwashiorkor; Lipoproteins; Liver; Male; Pigments, Biological; Protein Deficiency; Reticulin; Staining and Labeling; Vitamin E; Zinc

1968
Biochemical, pathological, and genetic aspects of a spontaneous mouse hepatoma.
    Journal of the National Cancer Institute, 1969, Volume: 43, Issue:2

    Topics: Age Factors; Animals; Carcinoma, Hepatocellular; Diet; Fatty Liver; Female; Hybridization, Genetic; Karyotyping; L-Serine Dehydratase; Liver; Liver Neoplasms; Male; Methylation; Mice; Neoplasms, Experimental; Rats; RNA, Transfer; Sex Factors; Transaminases; Transferases; Vitamin E

1969
Effect of alpha-tocopherol and tocopheronolactone on ethanol induced fatty liver and triglyceridemia.
    Experientia, 1970, Dec-15, Volume: 26, Issue:12

    Topics: Animals; Blood Protein Electrophoresis; Ethanol; Fatty Liver; Female; Hyperlipidemias; Lactones; Lipoproteins; Liver; NAD; Rats; Triglycerides; Vitamin E

1970
The effect of alpha-tocopherol on cerium induced changes in drug and lipid metabolism of rat.
    Experientia, 1974, Sep-15, Volume: 30, Issue:9

    Topics: Animals; Cerium; Cytochrome P-450 Enzyme System; Fatty Acids, Nonesterified; Fatty Liver; Glucose-6-Phosphatase; Lipid Metabolism; Liver; Male; Microsomes, Liver; Rats; Triglycerides; Vitamin E

1974
Interactions of dietary alpha-tocopherol, oxidized menhaden oil and ethoxyquin on channel catfish (Ictalurus punctatus).
    The Journal of nutrition, 1974, Volume: 104, Issue:11

    Topics: Animal Nutritional Physiological Phenomena; Animals; Antioxidants; Body Weight; Dietary Fats; Ethyl Ethers; Fatty Acids, Unsaturated; Fatty Liver; Fish Diseases; Fish Oils; Fishes; Muscular Diseases; Muscular Dystrophy, Animal; Oils; Oxidation-Reduction; Peroxides; Pigmentation Disorders; Quinolines; Vitamin E; Vitamin E Deficiency

1974
Failure of vitamin supplementation to alter the fatty liver syndrome caused by aflatoxin.
    Poultry science, 1972, Volume: 51, Issue:2

    Topics: Aflatoxins; Animals; Aspergillus flavus; Chickens; Choline; Fatty Liver; Female; Inositol; Lipids; Liver; Poultry Diseases; Syndrome; Vitamin B 12; Vitamin E; Vitamins

1972
Fatty liver induction: effect of ethionine on polyunsaturated fatty acid synthesis.
    Biochimica et biophysica acta, 1973, Feb-14, Volume: 296, Issue:2

    Topics: Acetates; Animals; Body Weight; Carbon Isotopes; Cytochrome P-450 Enzyme System; Edetic Acid; Ethionine; Fatty Acid Desaturases; Fatty Acids, Unsaturated; Fatty Liver; Female; Fluorescence; Linoleic Acids; Liver; Male; Microsomes, Liver; Orotic Acid; Phospholipids; Rats; Vitamin E

1973
Effect of diet on fatty liver-hemorrhagic syndrome incidence in laying chickens.
    Poultry science, 1972, Volume: 51, Issue:6

    Topics: Animals; Body Weight; Chickens; Choline; Cobalt; Diet; Fatty Liver; Female; Hemorrhage; Inositol; Lipids; Liver; Methionine; Poultry Diseases; Selenium; Syndrome; Vitamin B 12; Vitamin E

1972
Antioxidants, lipid peroxidation and chemical-induced liver injury.
    Federation proceedings, 1973, Volume: 32, Issue:8

    Topics: Alcoholic Intoxication; Alkenes; Animals; Antioxidants; Ascorbic Acid; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Diet; Ethanol; Fatty Liver; Humans; Lipid Metabolism; Lipids; Liver; Neurologic Manifestations; Pyrazoles; Rats; Triglycerides; Vitamin E; Vitamin E Deficiency

1973
Nutritional interrelationships among vitamin E, selenium, antioxidants and ethyl alcohol in the rat.
    The Journal of nutrition, 1973, Volume: 103, Issue:4

    Topics: Alcoholism; Animal Nutritional Physiological Phenomena; Animals; Antioxidants; Body Weight; Deficiency Diseases; Drug Synergism; Ethanol; Fatty Liver; Humans; Liver; Male; Necrosis; Oxygen Consumption; Rats; Selenium; Triglycerides; Vitamin E; Vitamin E Deficiency

1973
The effect of dietary lipids and alpha-tocopherol on RES activity in choline deficiency. Res and fatty livers.
    Journal of the Reticuloendothelial Society, 1971, Volume: 10, Issue:4

    Topics: Animals; Antioxidants; Carbon; Choline Deficiency; Dietary Fats; Fatty Acids, Essential; Fatty Liver; Liver; Male; Mononuclear Phagocyte System; Phagocytosis; Rats; Triglycerides; Vitamin E

1971
Hydrogenated marine fat, effect on growth and liver weight in young rats given a high fat, low protein ration.
    Nutrition and metabolism, 1971, Volume: 13, Issue:3

    Topics: Animal Nutritional Physiological Phenomena; Animals; Body Weight; Cocos; Dietary Fats; Dietary Proteins; Fats, Unsaturated; Fatty Acids; Fatty Liver; Feces; Fishes; Glycine max; Hydrogenation; Lipid Metabolism; Liver; Metals; Oils; Organ Size; Proteins; Rats; Stimulation, Chemical; Vitamin E

1971
The potentiation by amitriptyline of liver changes induced by ethanol in mice.
    Pathology, 1969, Volume: 1, Issue:2

    Topics: Administration, Oral; Amitriptyline; Animals; Antioxidants; Cytoplasm; Drug Synergism; Ethanol; Fatty Liver; Liver; Mice; Placebos; Vitamin E

1969
Methionine-responsive liver damage in young pigs fed a diet low in protien and vitamin E.
    The Journal of nutrition, 1968, Volume: 95, Issue:4

    Topics: Animals; Aspartate Aminotransferases; Blood Proteins; Body Weight; Choline; Diet; Fatty Liver; Female; Lipid Metabolism; Liver; Liver Diseases; Male; Methionine; Necrosis; Protein Deficiency; Selenium; Swine; Time Factors; Vitamin E; Vitamin E Deficiency

1968
Vitamin E and hepatotoxic agents. 2. Lipid peroxidation and poisoning with orotic acid, ethanol and thioacetamide in rats.
    The British journal of nutrition, 1969, Volume: 23, Issue:2

    Topics: Aldehydes; Amides; Aniline Compounds; Animals; Ethanol; Fatty Liver; In Vitro Techniques; Lipid Metabolism; Liver; Orotic Acid; Peroxides; Rats; Selenium; Sulfhydryl Compounds; Triglycerides; Vitamin E; Vitamin E Deficiency

1969
[Urinary elimination of 17-ketosteroids in experimental steatosis due to cholesterin and in steatosis due to cholesterin treated with methylating substances, testosterone and vitamin E (experimental research)].
    Chirurgia e patologia sperimentale, 1964, Volume: 12, Issue:10

    Topics: 17-Ketosteroids; Animals; Betaine; Cholesterol; Choline; Fatty Liver; Quaternary Ammonium Compounds; Rabbits; Testosterone; Urine; Vitamin E

1964
Hepatic changes associated with chronic alcoholism in rats.
    Laboratory investigation; a journal of technical methods and pathology, 1965, Volume: 14, Issue:8

    Topics: Alcoholism; Animals; Chemical and Drug Induced Liver Injury; Diet; Fatty Liver; Humans; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Rats; Vitamin E

1965
Pathogenesis of fatty liver--a postulated mechanism.
    The American journal of clinical nutrition, 1966, Volume: 19, Issue:4

    Topics: Antioxidants; Fatty Liver; Glycerides; Humans; Lipid Metabolism; Liver; Triglycerides; Vitamin E

1966
The effects of feeding rabbits a vitamin E-low diet containing oleic acid.
    American journal of veterinary research, 1966, Volume: 27, Issue:118

    Topics: Adipose Tissue; Animals; Aorta, Thoracic; Body Composition; Brain Chemistry; Brain Diseases; Diet; Dietary Fats; Fatty Acids; Fatty Liver; Growth; Kidney; Liver; Muscles; Myocardium; Oleic Acids; Organ Size; Rabbits; Vitamin E; Vitamin E Deficiency

1966